Efficacy and tolerability of alpha-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial
Di Nardo G, Oliva S, Ferrari F
Published in BMC Gastroenterology
Methodology
Randomised, double-blind, placebo-controlled crossover trial of oral alpha-galactosidase in children with gas-related abdominal symptoms
Key Findings
Alpha-galactosidase reduced global gas-related symptom scores compared with placebo
Conclusions
Targeted enzyme supplementation can reduce fermentation-driven symptoms after carbohydrate-rich meals
Limitations
Small paediatric sample; short exposure
Supplements Studied
Efficacy and tolerability of alpha-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial.
Outcomes Measured
Efficacy and tolerability of alpha-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial.
alpha-galactosidase has been shown to reduce gas production and related symptoms in adults.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.